Position in ARWR
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$110,276,346
+$100,924,767 QoQ
Shares Held
1,352,918
+807.1% QoQ
Ownership
0.958%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#15
of 497 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $2,824,813,122 across 97 Biotechnology names. ARWR ranks #10 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
547,132 | $341,158,687 | |
| 2 | INCY |
Incyte Corp
|
1,587,996 | $180,015,226 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
1,829,545 | $159,078,937 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
289,179 | $143,643,884 | |
| 5 | EXEL |
Exelixis, Inc.
|
2,543,353 | $138,383,836 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
421,534 | $126,894,380 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
324,900 | $120,755,583 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
482,061 | $117,994,070 |
All Filings in ARWR
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $110,276,346 | 1,352,918 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $9,351,579 | 149,148 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $15,782,894 | 237,730 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,172,367 | 207,955 | Shares | Sole | 2025-11-12 | |
| 2023-03-31 | $1,666,417 | 65,607 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $500,429 | 12,338 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $413,058 | 12,498 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $439,710 | 9,561 | Shares | Sole | 2022-05-13 | |
| 2021-09-30 | $1,795,112 | 28,754 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $2,304,802 | 34,758 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,932,214 | 25,182 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $2,922,654 | 67,874 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $3,322,736 | 76,933 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $2,525,027 | 87,766 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||